Detalhe da pesquisa
1.
Promising aryl selenoate derivatives as antileishmanial agents and their effects on gene expression.
Antimicrob Agents Chemother
; 68(4): e0155923, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497616
2.
Selenium and protozoan parasitic infections: selenocompounds and selenoproteins potential.
Parasitol Res
; 121(1): 49-62, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34993638
3.
The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells.
Int J Mol Sci
; 23(21)2022 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36361992
4.
Potential therapeutic targets shared between leishmaniasis and cancer.
Parasitology
; 148(6): 655-671, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33536086
5.
In Leishmania major, the Homolog of the Oncogene PES1 May Play a Critical Role in Parasite Infectivity.
Int J Mol Sci
; 22(22)2021 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830469
6.
Discovery and Validation of Lmj_04_BRCT Domain, a Novel Therapeutic Target: Identification of Candidate Drugs for Leishmaniasis.
Int J Mol Sci
; 22(19)2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638841
7.
Leishmanicidal Activity of Isoselenocyanate Derivatives.
Antimicrob Agents Chemother
; 63(2)2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478164
8.
Leishmanicidal activities of novel methylseleno-imidocarbamates.
Antimicrob Agents Chemother
; 59(9): 5705-13, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149985
9.
BRCT Domains: Structure, Functions, and Implications in Disease-New Therapeutic Targets for Innovative Drug Discovery against Infections.
Pharmaceutics
; 15(7)2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37514027
10.
Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease.
Pathogens
; 12(7)2023 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37513786
11.
Characterization of Leishmania Parasites Isolated from Naturally Infected Mammals.
Animals (Basel)
; 13(13)2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37443951
12.
Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis.
Pharmaceutics
; 14(11)2022 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36432719
13.
DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery.
Proc Biol Sci
; 277(1689): 1777-87, 2010 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20200034
14.
LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome.
Biomedicines
; 8(11)2020 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33114674
15.
Chitin binding protein as a possible RNA binding protein in Leishmania parasites.
Pathog Dis
; 78(1)2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32053190
16.
Structural characterization by scattering and spectroscopic methods and biological evaluation of polymeric micelles of poloxamines and TPGS as nanocarriers for miltefosine delivery.
Int J Pharm
; 578: 119057, 2020 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31991188
17.
Novel findings on trypanosomatid chemotherapy using DNA topoisomerase inhibitors.
Mini Rev Med Chem
; 9(6): 674-86, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19519493
18.
The Novel Serine/Threonine Protein Kinase LmjF.22.0810 from Leishmania major may be Involved in the Resistance to Drugs such as Paromomycin.
Biomolecules
; 9(11)2019 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718000
19.
Serological survey of cattle toxoplasmosis in Medea, Algeria.
Vet Parasitol Reg Stud Reports
; 12: 89-90, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31014815
20.
Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.
J Dermatol Sci
; 92(1): 78-88, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30037731